from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2720/lexA

LFCtreatmentdescriptionclass of inhibitor

0.447

Amikacinug/mL Amikacintranslation

-0.045

Cap5-10ug/mL Capreomycintranslation

0.144

Rox10-50 ug/mL Roxithromycintranslation

0.315

SM2-5 ug/mL Streptomycintranslation

1.288

Tet5-10 ug/mL Tetracyclinetranslation

0.150

Rif0.2-5ug/mL Rifampicintranscription

0.253

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.236

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.034

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.696

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.428

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.646

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.188

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.548

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.217

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.661

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.099

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.898

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.967

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.765

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.684

KCN5-20 ug/mL Potassium cyaniderespiration

-0.085

NaN30.2-2 mM Sodium aziderespiration

-0.871

Nigericin50 uM Nigericinrespiration

-0.016

TRC10-150 ug/mL Triclosanrespiration

-0.883

TRZ10-25 ug/mL Thioridazinerespiration

-0.195

Valinomycin0.5-10 uM Valinomycinrespiration

-0.436

ZnSO42 mM ZnSO4respiration

-0.320

menadione6-10 ug/mL Menadionerespiration

-0.614

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.378

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.309

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.377

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.186

NRP_1Non-replicating persistence stage 1dosRassociated

0.215

Amp0.2mg/mL AmpicillincellWall

-0.437

Cephalexin20-100 ug/mL CephalexincellWall

-0.074

Cerulenin0.32-5 ug/mL CerulenincellWall

0.002

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.102

EMB10-20 ug/mL EthambutolcellWall

-0.280

Eta12-40 ug/mL EthionamidecellWall

-0.051

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.007

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.669

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.892

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.031

BZA0.12 mg/mL BenzamidearomaticAmides

0.144

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.153

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.112

H2O24 mM hydrogen peroxideDNAdamaging

-0.029

Levo10 ug/mL LevofloxacinDNAdamaging

0.748

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.643

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.755

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.458

UVUV-irradiationDNAdamaging

-0.566

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.316

Antimycin12.5-50 ug/mL Antimycin A?

-0.318

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.013

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.374

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.833

PA8240.2-2 ug/mL PA-824?

0.601

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.147

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.664

Verapamil50 uM Verapamil?

-0.464

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.679

methoxatin10-20 ug/mL Methoxatin?